An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action.
látky serotonergné látky sérotonínové látky serotonínergné látky serotonergické efekt serotonínový efekty serotonínergické
Vysvetľujúca pozn. v angl.
Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.
Odkazy
(12) - ČLÁNKY
(8) - heslo MeSH
(5) - CiBaMed
(1) - KNIHY
predmetové heslo
openseadragon
Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom
ako používame cookies.
